Disparities in adoption of new diabetic therapies with cardiovascular benefits-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Disparities in adoption of new diabetic therapies with cardiovascular benefits

Published:2023-02 Issue: Volume:196 Page:110233
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Vasti Elena C.,Basina Marina,Calma Jamie,Maron David J.,Rodriguez Fatima,Sandhu Alexander T.

Funder

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference38 articles.

1. National Diabetes Statistics Report. US Department of Health and Human Services, Centers for Disease Control and Prevention. 2020.

2. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data;Gregg;Lancet,2018

3. Diabetes mellitus, fasting blood glucose concentration and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies;Collaboration;Lancet,2010

4. Cardiovascular outcomes with glucagon-like peptide 1 receptor agonists with type 2 diabetes: a meta-analysis;Bethel;Lancet Diab Endocrinol,2018

5. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes;Marso;NEJM,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Achieving equitable access to incretin-based therapies in cardiovascular care;American Heart Journal Plus: Cardiology Research and Practice;2024-10

2. Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex;Journal of General Internal Medicine;2023-12-14

3. Glucose‐lowering drug use in migrants and native Danes with type 2 diabetes: Disparities in combination therapy and drug types;Diabetes, Obesity and Metabolism;2023-08-07

4. Socioeconomic aspects of incretin-based therapy;Diabetologia;2023-07-12

5. Expanding Use of Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) In Managing Patients with Diabetes and Chronic Kidney Disease in Primary Care

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3